Sarepta stock

See also: SareptaSarepta therapeutics stockSarepta stockSarepta quoteSarepta therapeuticsSareptah

Keywords Suggestions

Sarepta stock

Sarepta stocktwits

Sarepta stock news

Sarepta stock chart

Sarepta stock jumps

Sarepta stock quote

Sarepta stock split

Sarepta stock today

Sarepta stock future

Sarepta stock price

Sarepta stock symbol

Sarepta stock history

Sarepta stock outlook

Sarepta stock forecast

Sarepta stock after hours

Sarepta stock price today

Sarepta stock price yahoo

Sarepta stock target price

Sarepta stock price forecast

( Please select at least 2 keywords )

Related websites

Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote

  • Find the latest Sarepta Therapeutics, Inc
  • (SRPT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com   DA: 17 PA: 11 MOZ Rank: 29

SRPT Stock Price Sarepta Therapeutics Inc. Stock Quote

  • SRPT | Complete Sarepta Therapeutics Inc
  • View real-time stock prices and stock quotes for a full financial overview.

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 42

SRPT Sarepta Therapeutics Inc. Stock Price & News

  • News Sarepta Therapeutics Inc.SRPT
  • The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price …

Wsj.com   DA: 11 PA: 24 MOZ Rank: 38

Sarepta Therapeutics, Inc. (SRPT) Stock Forum & …

  • Find the latest Sarepta Therapeutics, Inc
  • (SRPT) stock discussion in Yahoo Finance's forum
  • Share your opinion and gain insight from other stock traders and investors.

Finance.yahoo.com   DA: 17 PA: 21 MOZ Rank: 42

Sarepta Therapeutics, Inc. (SRPT) Stock Price Today, Quote

  • A high-level overview of Sarepta Therapeutics, Inc
  • Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Seekingalpha.com   DA: 16 PA: 12 MOZ Rank: 33

SRPT Sarepta Therapeutics Inc. — Stock Price and

  • NASDAQ Updated Oct 15, 2021 11:55 PM SRPT 84.19 1.19 (1.43%)

Stocktwits.com   DA: 14 PA: 12 MOZ Rank: 32

SRPT Stock Forecast, Price & News (Sarepta Therapeutics)

  • 20 brokers have issued twelve-month target prices for Sarepta Therapeutics' shares
  • Their forecasts range from $75.00 to $215.00
  • On average, they expect Sarepta Therapeutics' share price to reach $132.65 in the next twelve months
  • This suggests a possible upside of 62.0% from the stock's current price
  • View analysts' price targets for Sarepta

Marketbeat.com   DA: 18 PA: 20 MOZ Rank: 45

What's Next For Sarepta Stock After A 12% Fall

1 day ago · Sarepta Therapeutics stock rose 3.7% the last twenty-one trading days (one month), compared to broader market (S&P500) decline of 2.0%; A change of 3.7% or more over twenty-one trading days is a

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 72

Sarepta Therapeutics Stock Forecast

  • The Sarepta Therapeutics stock price fell by -0.26% on the last day (Thursday, 14th Oct 2021) from $83.22 to $83.00
  • and has now fallen 3 days in a row.During the day the stock fluctuated 4.23% from a day low at $82.27 to a day high of $85.75.The price has been going up and down for this period, and there has been a -10.25% loss for the last 2 weeks.

Stockinvest.us   DA: 14 PA: 11 MOZ Rank: 34

Why Sarepta Therapeutics Tumbled Today The Motley Fool

  • As for the share issue, Sarepta divulged that it is floating $500 million worth of its common stock in an underwritten public offering

Fool.com   DA: 12 PA: 50 MOZ Rank: 72

Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote

  • Sarepta Therapeutics Announces Pricing of $500 Million Public Offering of Common Stock
  • 13, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has priced an underwritten public offering of 6,172,840 shares of its common stock at a …

Ca.finance.yahoo.com   DA: 20 PA: 11 MOZ Rank: 42

SRPT: Sarepta Therapeutics Inc

Get Sarepta Therapeutics Inc (SRPT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 36

SRPT Stock Rockets After Biotech Company's New DMD Drug

  • On an annual basis, Vyondys 53 could generate $500 million in sales for Sarepta, Auster said in a note
  • He reiterated his outperform rating and 190 price target on SRPT stock

Investors.com   DA: 17 PA: 50 MOZ Rank: 80

How Does Sarepta's Stock Performance In The Current Crisis

  • SRPT stock trades under $80 levels currently and it is, in fact, down 37% from its pre-Covid high of around $125 in February 2020 – before the coronavirus pandemic hit the world

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 78

SRPT Stock News SAREPTA THERAPEUTICS Stock Price Today

SRPT: Get the latest Sarepta Therapeutics stock price and detailed information including SRPT news, historical charts and realtime prices.

Markets.businessinsider.com   DA: 27 PA: 18 MOZ Rank: 60

Sarepta Stock Sinks After Announcing a Stock Sale. It's

  • Sarepta Therapeutics stock is falling after the biotech company said it would sell more stock and provided an update on product revenue
  • Sarepta said that it would post third-quarter sales of $166

Barrons.com   DA: 15 PA: 46 MOZ Rank: 77

Sarepta Stock Is Down 57% This Year. Why the Biotech Could

Sarepta’s (ticker: SRPT) plummet is the third-worst this year of any midcap or larger stock in either of the two key biotech exchange-traded funds, the iShares Biotechnology ETF (IBB) and the

Barrons.com   DA: 15 PA: 50 MOZ Rank: 82

SRPT Price Target, Analyst Ratings & Predictions (Sarepta

  • According to the issued ratings of 21 analysts in the last year, the consensus rating for Sarepta Therapeutics stock is Buy based on the current 9 hold ratings and 12 buy ratings for SRPT
  • The average twelve-month price target for Sarepta Therapeutics is $132.65 with a high price target of $215.00 and a low price target of $75.00

Marketbeat.com   DA: 18 PA: 33 MOZ Rank: 69

Sarepta Stock Pops After FDA Places Rival's Gene Therapy

  • RBC's Abrahams kept his outperform rating on Sarepta stock
  • He noted the total market for a gene therapy for Duchenne muscular dystrophy could be as much as $4 billion

Investors.com   DA: 17 PA: 50 MOZ Rank: 86

Sarepta Therapeutics, Inc.

  • SRPT investment & stock information
  • Get the latest Sarepta Therapeutics, Inc
  • SRPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Zacks.com   DA: 13 PA: 17 MOZ Rank: 50

Sarepta Therapeutics Biopharmaceutical Company for Rare

Sarepta Therapeutics Announces Pricing of $500 Million Public Offering of Common Stock 10/12/2021 Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quarter Ended September 30, 2021

Sarepta.com   DA: 15 PA: 15 MOZ Rank: 51

After A 50% Fall Sarepta Therapeutics Stock Now Looks

  • Sarepta Therapeutics stock, is a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases

Forbes.com   DA: 14 PA: 50 MOZ Rank: 86

SRPT Stock Price and Chart — NASDAQ:SRPT

  • View live Sarepta Therapeutics, Inc chart to track its stock's price action
  • Find market predictions, SRPT financials and market news.

Tradingview.com   DA: 19 PA: 21 MOZ Rank: 63

$SRPT: Investors will love the forecast for Sarepta

  • Market cap measures what a company is worth on the open market, as well as the market’s perception of its prospects because it reflects what investors are willing to pay for its stock
  • Sarepta Therapeutics Inc has a market cap of $6722121278
  • Stock analysis is a method for investors and traders to make buying and selling decisions.

Wallstreetfacts.com   DA: 19 PA: 50 MOZ Rank: 93

How Does Sarepta’s Stock Performance In The Current Crisis

Sarepta hasn’t had a great year thus far with its stock plummeting over 52% from levels of around $165 toward the beginning of the year to $79 now.

Forbes.com   DA: 14 PA: 50 MOZ Rank: 89

Buy or Sell Sarepta Therapeutics Inc. (SRPT) Stock Now

  • (NASDAQ:SRPT) went down by -3.53% from its latest closing price compared to the recent 1-year high of $181.83
  • The company’s stock price has collected -11.03% of loss in the last five trading sessions
  • Press Release reported 12 hours ago that Lysogene Announces a Presenta

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 90

Sarepta Therapeutics Inc. (NASDAQ: SRPT) Reports

  • 15 hours ago · Sarepta Therapeutics Inc
  • (NASDAQ: SRPT) has announced its preliminary Q3 2021 financial results
  • The company expects net product revenues of $166.9 million relative to net revenue of $121.4 million a year ago
  • Sarepta has $1.6 billion in cash and equivalents

Biopharmajournal.com   DA: 20 PA: 50 MOZ Rank: 97

Sarepta Therapeutics (SRPT) Stock Message Board

Company Name: Sarepta Therapeutics, Stock Symbol: SRPT, Industry: Biotechs, Total Posts: 3014, Last Post: 10/13/2021 4:02:30 PM

Investorshub.advfn.com   DA: 22 PA: 32 MOZ Rank: 82

Should You Buy Sarepta Stock At $71

We believe that the stock price of Sarepta Therapeutics (NASDAQ:SRPT), a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of

Trefis.com   DA: 14 PA: 50 MOZ Rank: 93

Sarepta Therapeutics Inc (SRPT) Quote

  • Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases
  • Sponsor Center Transparency is our

Morningstar.com   DA: 19 PA: 23 MOZ Rank: 72

Buy shares of Sarepta Therapeutics Inc stock (SRPT) Stash

  • How to buy Sarepta Therapeutics Inc stock on Stash
  • Enter the amount you'd like to invest in Sarepta Therapeutics Inc stock, then proceed to checkout
  • Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Stash.com   DA: 13 PA: 50 MOZ Rank: 94

Sarepta Therapeutics: Faultlines May Run Deeper Than

  • Sarepta Therapeutics stock went down over 50% after poor January data
  • Unless it can prove functional benefit from its DMD drugs, …

Seekingalpha.com   DA: 16 PA: 50 MOZ Rank: 98

Sarepta Stock Price (SRPT)

Get today's Sarepta Therapeutics Inc stock price and latest SRPT news as well as Sarepta real-time stock quotes, technical analysis, full financials and more.

Investing.com   DA: 17 PA: 17 MOZ Rank: 67

Stock Quote Sarepta Therapeutics, Inc.

The Investor Relations website contains information about Sarepta Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

Investorrelations.sarepta.com   DA: 29 PA: 30 MOZ Rank: 93

Sarepta Therapeutics

  • (Nasdaq: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 …

En.wikipedia.org   DA: 16 PA: 26 MOZ Rank: 77

Should I buy Sarepta Therapeutics, Inc. (SRPT)

  • So, when comparing one stock to another in a different industry, it's best make relative comparisons to that stock's respective industry values

Zacks.com   DA: 13 PA: 40 MOZ Rank: 89

What’s Next For Sarepta Stock After A 12% Fall

The stock price of Sarepta Therapeutics, a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases, plunged 12% yesterday, while it is down 14% in the last five trading days.

Tradersnewssource.com   DA: 21 PA: 46 MOZ Rank: 13

What's next for Sarepta stock after a 12% drop

  • BRAZIL - 2021/02/18: In this photo, a Sarepta Therapeutics logo is displayed on a smartphone with stock market graph in the background

Theusexpressnews.com   DA: 24 PA: 46 MOZ Rank: 12

SRPT Stock: Positive Spin Isn’t Working for Sarepta

  • Nevertheless, many analysts view SRPT stock as a buying opportunity and recently, they received support for their optimism
  • Last month, Sarepta disclosed results from its testing of a low dose of

Investorplace.com   DA: 17 PA: 50 MOZ Rank: 11

Do Analysts Agree Wednesday on Sarepta Therapeutics Inc

  • Analysts who follow Sarepta Therapeutics Inc on average expect it to gain 63.48% over the next twelve months.Those same analysts give the stock an average rating of Strong Buy
  • That average rating earns SRPT an Analyst Ranking of 39, which means it ranks higher than 39 of stocks, based on data compiled by InvestorsObserver.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 10

Sarepta Therapeutics Announces Proposed $500,000,000

  • Sarepta also intends to grant the underwriters a 30-day option to purchase up to an additional $75,000,000 in shares of its common stock
  • Morgan Securities LLC, Morgan Stanley & Co
  • LLC and Credit Suisse Securities (USA) LLC are acting as the underwriters of the proposed offering.

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 9

Medical sector's Sarepta Therapeutics (NASDAQ:SRPT)'s Hold

  • Sarepta Therapeutics (NASDAQ:SRPT)‘s stock had its Hold rating Reiterated by analysts at Berenberg Bank – 4 stars in a research report issued to clients and investors
  • A price-to-earnings ratio of #N/A, market cap of 6.7B and a beta of 1.42
  • Sarepta Therapeutics has a twelve month low $65.30 of and a twelve month high of $181.83.

Stockmarketdaily.co   DA: 19 PA: 50 MOZ Rank: 8

Here's Why Sarepta Therapeutics Fell 16.5% in September

  • Shares of Sarepta Therapeutics ( NASDAQ:SRPT) slid over 16% last month, according to data from S&P Global Market Intelligence
  • The stock's September tumble was an extension of what began a month

Fool.com   DA: 12 PA: 50 MOZ Rank: 7

Expert Ratings For Sarepta Therapeutics Markets Insider

  • In the last 3 months, 6 analysts have offered 12-month price targets for Sarepta Therapeutics
  • The company has an average price target …

Markets.businessinsider.com   DA: 27 PA: 50 MOZ Rank: 6

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Gws-offshore.com 76 days leftHosting Concepts B.V. d/b/a OpenproviderRIPE Network Coordination Centre
Ioanna-auschra.com 219 days leftCronon AGAmazon Technologies Inc.
Romefloydsportshalloffame.com4 years, 141 days leftGoDaddy.com, LLCDomain Name Services
Lincedge.com 283 days leftRebel LtdGoogle LLC
Urbanfarmacypdx.com3 years, 340 days leftDomain.com, LLCAmazon Technologies Inc.
Thebluegillpond.com 199 days leftDomain.com, LLCLiquid Web, L.L.C
Descent.net1 year, 313 days leftGoDaddy.com, LLCDigitalOcean, LLC
Theparismarket.com 106 days leftTucows Domains Inc.Cloudflare, Inc.
Brothersofbriar.com 50 days leftGoDaddy.com, LLCCloudflare, Inc.
Hammontongazette.com9 years, 233 days leftNetwork Solutions, LLCGoogle LLC

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]